Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials
- 30 November 1996
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 62 (5) , 1404-1411
- https://doi.org/10.1016/0003-4975(96)00634-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Biocompatibility of extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin- alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypassBlood, 1989
- Pharmacological Studies of FUT-175, Nafamstat Mesilate I. Inhibition of Protease Activity in in Vitro and in Vivo ExperimentsThe Japanese Journal of Pharmacology, 1984
- Platelet function during cardiac operationThe Journal of Thoracic and Cardiovascular Surgery, 1982
- Inhibition of Various Immunological Reactions in vivo by a New Synthetic Complement InhibitorInternational Archives of Allergy and Immunology, 1981
- New synthetic inhibitors of C1r̄, C1 esterase, thrombin, plasmin, kallikrein and trypsinBiochimica et Biophysica Acta (BBA) - Enzymology, 1981